The Managing Director of Healthcare Ltd, Nelson Maduabuchi, has lamented the widespread and destructive effects of malaria to the liver of people in the tropics including Nigeria due to the prevalence of mosquitoes.

The chief executive of the company in his address during the launch and donation of Antecxin malaria drug to Ebonyi State Government in Abakalika regretted that malaria has become one of the leading killer diseases in Nigeria where, according to the World Health Organization (WHO), malaria has plagued humanity from ancient times and still haunts 40 per cent of the world’s population today.

“The disease infects over 500 million people every year and kills well over one million annually and in Nigeria, it is estimated that the disease kills about 300,000 people annually.” He said that it was against this back-Drop that the federal government launched a full-scale war against the deadly disease and has encouraged and funded research works into the invention of the drugs that would effectively dislodge the malaria scourge.

Mduabuchi observed that as a corporate citizen and in an effort to give back to the society, the company undertook series of researches that culminated in Artecrin, “a novel and malaria drug which we are launching today in Ebonyi State.”According to him, “Artecxin is a brand of Artemisinin based combination thereby,” a drug widely acclaimed for its efficacy in the total cure of all resistant forms of malaria.

Some other special qualities of the drug, he noted, “is that it has a short treatment course which ensures that patients comply with their medications as prescribed, high efficacy rate which is pegged at % percent and its little side effects.”

The Commissioner for Health, Ebonyi State, Dr Sunday Nwangele described the donation as a wonderful gesture from the company, adding that the state government was poised in medicating the malaria and HIV/AIDS scourge that have been high in the state.

O’Nell pharma earmarks N50 million for malaria drugs

REGIS ANUKWUOJI / ABAKALIKI

The management of O’Nell Pharma and Healthcare Limited says it has earmarked over N50million for a new anti malaria drug ARTECXIN, a brand of Artemisinin based combination therapy (ACT) to be distributed for free to both government and private-owned health intuitions in the 36 states of the federation.

Speaking while donating drugs worth (N2M) to Ebonyi State government, the managing director of O,Nell Pharma and Healthcare Ltd, Nelson Maduabuchi, said that the donation was their own contribution towards fighting the scourge of the malaria parasites in the society. He emphasized malaria as a leading killer disease in Nigeria annually as a result of the disease.

“According to the world Health Organisation (WHO) source, malaria has plagued humanity from ancient times and still hunts 40n percent of the world’s population today, “stating that it infests over five million people every year and kills well over one million annually.